Examining previous single-cell RNA-seq data by Neftel et al. [117], they identified HAVCR2 gene-expressing tumor cells and TIM-3 expression in primary tissue cell suspensions from clinical glioblastoma samples, and primary and established glioma cell lines [67]. This evidence concerns the gene HAVCR2 and central nervous system cancer.